Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $52.6 million.

  • Perspective Therapeutics' Total Liabilities fell 1607.0% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.6 million, marking a year-over-year decrease of 1607.0%. This contributed to the annual value of $50.4 million for FY2024, which is 12205.44% up from last year.
  • Per Perspective Therapeutics' latest filing, its Total Liabilities stood at $52.6 million for Q3 2025, which was down 1607.0% from $45.0 million recorded in Q2 2025.
  • Perspective Therapeutics' 5-year Total Liabilities high stood at $62.7 million for Q3 2024, and its period low was $2.9 million during Q4 2021.
  • Moreover, its 5-year median value for Total Liabilities was $11.5 million (2023), whereas its average is $22.7 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 55850.97% in 2023, then tumbled by 1607.0% in 2025.
  • Over the past 5 years, Perspective Therapeutics' Total Liabilities (Quarter) stood at $2.9 million in 2021, then grew by 20.55% to $3.4 million in 2022, then soared by 558.51% to $22.7 million in 2023, then skyrocketed by 122.05% to $50.4 million in 2024, then grew by 4.31% to $52.6 million in 2025.
  • Its Total Liabilities stands at $52.6 million for Q3 2025, versus $45.0 million for Q2 2025 and $44.7 million for Q1 2025.